# Study to Evaluate Efficacy, Safety and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster (HZ) Vaccine GSK1437173A in Adults Aged 70 Years and Older

> **NCT01165229** · PHASE3 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 14819 (actual)

## Conditions studied

- Herpes Zoster
- Herpes Zoster Vaccine

## Interventions

- **BIOLOGICAL:** Herpes Zoster Vaccine GSK1437173A
- **BIOLOGICAL:** Placebo

## Key facts

- **NCT ID:** NCT01165229
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-08-02
- **Primary completion:** 2015-07-24
- **Final completion:** 2015-07-24
- **Target enrollment:** 14819 (ACTUAL)
- **Last updated:** 2020-04-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01165229

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01165229, "Study to Evaluate Efficacy, Safety and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster (HZ) Vaccine GSK1437173A in Adults Aged 70 Years and Older". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01165229. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*